Mark Corrigan's Net Worth

$11.5 Million

Estimate Recalculated Nov 1, 2024 04:54AM EST

Who is Mark Corrigan?

Mark Corrigan has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, CoLucid Pharmaceuticals, Inc., Nabriva Therapeutics plc, NOVELION THERAPEUTICS INC., Wave Life Sciences Ltd., TREVENA INC, CUBIST PHARMACEUTICALS INC, EPIRUS Biopharmaceuticals, Inc., AVANIR PHARMACEUTICALS, INC., and SEPRACOR INC /DE/.

SEC CIK

Mark Corrigan's CIK is 0001250661

Past Insider Trading and Trends

2004 was Mark Corrigan's most active year for acquiring shares with 13 total transactions. Mark Corrigan's most active month to acquire stocks was the month of May. 2007 was Mark Corrigan's most active year for disposing of shares, totalling 72 transactions. Mark Corrigan's most active month to dispose stocks was the month of May. 2005 saw Mark Corrigan paying a total of $9,017,600.00 for 240,000 shares, this is the most they've acquired in one year. In 2007 Mark Corrigan cashed out on 351,382 shares for a total of $11,528,832.79, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nabriva Therapeutics Plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 23
No matching records found

CoLucid Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
Oct 27
Form 3
—
0
—
—
0
No matching records found

Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.00001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-58.84%
-10.30K
$0.19
-$1,956.43
7.2K
Aug 2
Form 4
∞
17.5K
—
—
17.5K
Jul 28
Form 4
—
0
—
—
0
Jun 2
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jul 31
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
Sep 15
Form 3
—
0
—
—
0
No matching records found

NOVELION THERAPEUTICS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 9
Form 4/A
—
0
—
—
0
Mar 30
Form 4
—
0
—
—
0
Mar 30
Form 3
—
0
—
—
0
No matching records found

Wave Life Sciences Ltd. (WVE) Snapshot price: $5.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
32.23K
—
—
32.23K
Aug 12
Form 4
—
0
—
—
0
Aug 7
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Aug 16
Form 4
—
0
—
—
0
Aug 18
Form 4
—
0
—
—
0
Sep 4
Form 3
—
0
—
—
0
No matching records found